Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.

OBJECTIVE The purpose of this study was to determine whether lesion type and size affect discrimination of benign and malignant breast lesions with diffusion-weighted MRI. MATERIALS AND METHODS This study included 91 women with 116 breast lesions identified with dynamic contrast-enhanced MRI. Diffusion-weighted images were acquired during clinical breast MRI at b values of 0 and 600 s/mm(2). Differences in the apparent diffusion coefficients (ADCs) of benign and malignant lesions were compared by lesion type (mass or nonmasslike enhancement) and size (<or= 1 cm or > 1 cm), and receiver operating characteristics analysis was performed to evaluate diagnostic performance based on ADC thresholds. RESULTS Sixteen of 71 masses and 13 of 45 lesions with nonmasslike enhancement were malignant. The mean ADC was significantly lower for malignant than for benign lesions for both masses (mean difference, 0.49 x 10(-3) mm(2)/s; p < 0.001) and lesions with nonmasslike enhancement (mean difference, 0.20 x 10(-3) mm(2)/s; p = 0.02). The area under the receiver operating characteristics curve (AUC) was greater for masses (AUC, 0.80) than for lesions with nonmasslike enhancement (AUC, 0.66). The mean ADC for malignant masses (1.25 x 10(-3) mm(2)/s) was lower than that for malignant lesions with nonmasslike enhancement (1.41 x 10(-3) mm(2)/s; p = 0.07). The median lesion size was 1.1 cm (range, 0.5-8.3 cm); 45 of 71 masses (63%) measured 1 cm or smaller, and 37 of 45 lesions with nonmasslike enhancement (82%) were larger than 1 cm. There was no relation (p > 0.05) between ADC value and lesion size for benign or malignant lesions, and there were no differences in AUC based on lesion size (p > 0.05). CONCLUSION Diffusion-weighted MRI shows promise in differentiation of benign and malignant masses and lesions with nonmasslike enhancement found at breast MRI and is not affected by lesion size. However, ADC measurements may be more useful for discriminating masses than for discriminating lesions with nonmasslike enhancement.

[1]  A. Hollingsworth,et al.  Breast magnetic resonance imaging for preoperative locoregional staging. , 2008, American journal of surgery.

[2]  Petrina Causer,et al.  MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883 , 2005, Journal of surgical oncology.

[3]  Elizabeth A Morris,et al.  Nonpalpable mammographically occult invasive breast cancers detected by MRI. , 2006, AJR. American journal of roentgenology.

[4]  Wendy B DeMartini,et al.  BI‐RADS MRI Enhancement Characteristics of Ductal Carcinoma In Situ , 2007, The breast journal.

[5]  Hiroshi Honda,et al.  Enhanced mass on contrast‐enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast‐enhanced and diffusion‐weighted MR images , 2008, Journal of magnetic resonance imaging : JMRI.

[6]  Ning-Yu An,et al.  Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[7]  K S Panageas,et al.  Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient. , 2001, Radiology.

[8]  Rebecca S Lewis,et al.  Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. , 2004, Radiology.

[9]  Ellen Warner,et al.  Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.

[10]  Satoko Matsumura,et al.  Quantitative diffusion-weighted magnetic resonance imaging as a powerful adjunct to fine needle aspiration cytology for assessment of thyroid nodules. , 2012, American journal of otolaryngology.

[11]  Wendy B DeMartini,et al.  Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. , 2009, AJR. American journal of roentgenology.

[12]  Elizabeth A Morris,et al.  MRI of occult breast carcinoma in a high-risk population. , 2003, AJR. American journal of roentgenology.

[13]  Hiroyuki Abe,et al.  DCEMRI of breast lesions: Is kinetic analysis equally effective for both mass and nonmass-like enhancement? , 2008, Medical physics.

[14]  Hiroshi Honda,et al.  Apparent diffusion coefficients of breast tumors: clinical application. , 2008, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[15]  Kaori Togashi,et al.  Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study. , 2011, Radiology.

[16]  Hiroshi Honda,et al.  Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. , 2010, European journal of radiology.

[17]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007 .

[18]  A. Cilotti,et al.  Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion , 2007, European Radiology.

[19]  M. Plana,et al.  Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis , 2011, European Radiology.

[20]  Katarzyna J Macura,et al.  Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

[21]  Sung Hun Kim,et al.  Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma , 2011, Journal of magnetic resonance imaging : JMRI.

[22]  P. Grenier,et al.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.

[23]  Usha Sinha,et al.  In vivo diffusion‐weighted MRI of the breast: Potential for lesion characterization , 2002, Journal of magnetic resonance imaging : JMRI.

[24]  M. I. Rosa,et al.  Accuracy of magnetic resonance in suspicious breast lesions: a systematic quantitative review and meta-analysis , 2011, Breast Cancer Research and Treatment.

[25]  G. Sonmez,et al.  Value of diffusion-weighted MRI in the differentiation of benign and malign breast lesions , 2011, Wiener klinische Wochenschrift.

[26]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[27]  I. Makhoul,et al.  Neoadjuvant systemic treatment of breast cancer , 2011, Journal of surgical oncology.

[28]  Thomas E. Yankeelov,et al.  On the relationship between the apparent diffusion coefficient and extravascular extracellular volume fraction in human breast cancer. , 2011, Magnetic resonance imaging.

[29]  M D Schnall,et al.  MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. , 2001, Radiology.

[30]  Thierry Metens,et al.  Quantitative diffusion imaging in breast cancer: A clinical prospective study , 2006, Journal of magnetic resonance imaging : JMRI.

[31]  Evelyn Wenkel,et al.  Diffusion weighted imaging in breast MRI: comparison of two different pulse sequences. , 2007, Academic radiology.

[32]  Saadallah Ramadan,et al.  Diffusion-weighted imaging of the breast: principles and clinical applications. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

[33]  C. Gatsonis,et al.  MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. , 2007, The New England journal of medicine.

[34]  J. Elmore,et al.  Ten-year risk of false positive screening mammograms and clinical breast examinations. , 1998, The New England journal of medicine.

[35]  C. Gatsonis,et al.  Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. , 2007, Radiology.

[36]  H. D. de Koning,et al.  Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.

[37]  Naobumi Yashiro,et al.  Diffusion-Weighted Half-Fourier Single-Shot Turbo Spin Echo Imaging in Breast Tumors: Differentiation of Invasive Ductal Carcinoma from Fibroadenoma , 2002, Journal of computer assisted tomography.

[38]  Masanori Ozaki,et al.  ADC mapping of benign and malignant breast tumors. , 2005, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.